Ginkgo Bioworks (DNA) announced that Mark Dmytruk, the company’s CFO, intends to resign from his role at the company on May 30 to accept a position at another organization and Steven Coen, CPA, the company’s Chief Accounting Officer, will become CFO, effective upon Dmytruk’s resignation. Coen joined the company on May 1, 2023 with over 30 years of public accounting and corporate finance leadership experience. Prior to his role at Ginkgo, Coen was the Corporate Vice President and Corporate Controller for Charles River Laboratories (CRL).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Sell Rating Reiterated for Ginkgo Bioworks Holdings Amid Revenue Visibility and Growth Concerns
- Largest borrow rate increases among liquid names
- Twist Bioscience, Ginkgo Bioworks revise collaboration agreement
- Ginkgo Bioworks Earnings Call: Optimism Amid Challenges
- Ginkgo Bioworks Reports Strong Q1 2025 Growth